SKI Market

A+| A| A-|

Indian Indices

Sensex

75,415.35 231.99
( 0.31%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

63,328.42 1,644.28
(2.67%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Astrazeneca Pharma India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

506820

INE203A01020

319.6

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ASTRAZEN

103.4

21510.63

EPS(TTM)

Face Value()

Div & Yield %

83.21

0.37

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1716.29	1295.53	1002.97	805.60	813.56	831.81
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1716.29	1295.53	1002.97	805.60	813.56	831.81
Other Income	40.63	51.23	26.10	14.76	12.84	12.99
Stock Adjustments	332.94	33.77	48.86	-14.47	-2.95	39.21
Total Income	2089.86	1380.53	1077.93	805.89	823.45	884.01
EXPENDITURE :
Raw Materials	1295.95	628.33	408.84	297.49	292.00	344.44
Power & Fuel Cost	5.30	4.87	5.54	8.10	7.37	7.72
Employee Cost	257.44	241.45	259.10	230.21	219.54	216.70
Other Manufacturing Expenses	18.45	14.38	13.79	8.05	9.11	9.04
Selling & Administrative Expenses	204.24	234.33	185.72	145.09	129.72	157.18
Miscellaneous Expenses	110.67	21.49	53.95	16.01	17.40	15.24
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1892.05	1144.85	926.94	704.95	675.14	750.32
Operating Profit	197.81	235.68	150.99	100.94	148.31	133.69
Interest	1.46	1.20	0.63	0.95	1.09	1.14
Gross Profit	196.35	234.48	150.36	99.99	147.22	132.55
Depreciation	39.99	14.94	16.26	16.95	20.13	18.58
Profit Before Tax	156.36	219.54	134.10	83.04	127.09	113.97
Tax	60.54	58.93	38.30	22.63	34.83	31.51
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-19.92	-0.90	-3.49	-1.19	-1.04	10.25
Reported Net Profit	115.74	161.51	99.29	61.60	93.30	72.21
Extraordinary Items	-59.39	12.45	-26.96	2.05	1.58	0.18
Adjusted Net Profit	175.13	149.06	126.25	59.55	91.72	72.03
Adjustment below Net Profit	-1.17	1.00	-2.61	-1.74	3.43	-5.56
P & L Balance brought forward	578.15	455.64	378.96	324.10	232.37	168.22
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	60.00	40.00	20.00	5.00	5.00	2.50
P & L Balance carried down	632.72	578.15	455.64	378.96	324.10	232.37
Dividend	0.00	0.00	0.00	5.00	5.00	2.50
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	1600.00	1200.00	800.00	500.00	100.00	50.00
Dividend Per Share(Rs)	32.00	24.00	16.00	10.00	2.00	1.00
Earnings Per Share-Unit Curr	46.30	64.60	39.72	24.64	37.32	28.88
Earnings Per Share(Adj)-Unit Curr	46.30	64.60	39.72	24.64	37.32	28.88
Book Value-Unit Curr	308.14	284.77	235.48	204.56	182.47	145.78
Book Value(Adj)-Unit Curr	308.14	284.77	235.48	204.56	182.47	145.78

75,415.35 231.99 ( 0.31%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

63,328.42 1,644.28 (2.67%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)